As the German subsidiary of the world's largest manufacturer and innovator of herbal Chinese medicine (parent company of Tasly Pharma/China), we bring you modernized TCM formulas to Europe and the MENA region. These formulas are manufactured in an FDA-certified facility according to EU-GMP standards and feature an additional Big Data safety profile (network pharmacology). Xiaoyao Ease tablets (for symptoms of depression such as burnout*) were the first TCM combination product to receive EU approval. Further preparations for migraine prophylaxis, endometriosis, and our international flagship product Dantonic (Danshen Dripping Pills, FDA approved for stable angina pectoris) are currently undergoing European approval or are in bridging clinical trials. Learn about Tasly's pioneering role in modernizing Traditional Chinese Medicine (TCM), including its patented Dripping Pill technology, its proprietary CloudPharm pharmacology network for safety profiles and gender personalization, its extensive range of TCM granules with over 500 individual substances, and other portfolio products. Our OneStop Agency can provide professional support throughout this process, whether you're traveling from Europe and the MENA region to China and Japan, or vice versa.